HEADER TRANSFERASE/CELL CYCLE 12-JUL-11 3ZTX TITLE AURORA KINASE SELECTIVE INHIBITORS IDENTIFIED USING A TAXOL- TITLE 2 INDUCED CHECKPOINT SENSITIVITY SCREEN. COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 12-A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 78-361; COMPND 5 SYNONYM: AURORA B, AURORA KINASE B-A, AURORA/IPL1-RELATED KINASE 2, COMPND 6 A XAIRK2, SERINE/THREONINE-PROTEIN KINASE AURORA-B-A, XAURORA-B; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: INNER CENTROMERE PROTEIN A; COMPND 11 CHAIN: C, D; COMPND 12 FRAGMENT: RESIDUES 797-840; COMPND 13 SYNONYM: XL-INCENP, XINC, XINCENP, MITOTIC PHOSPHOPROTEIN 130; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: XENOPUS LAEVIS; SOURCE 3 ORGANISM_TAXID: 8355; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: XENOPUS LAEVIS; SOURCE 8 ORGANISM_TAXID: 8355; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE-CELL CYCLE COMPLEX, TRANSFERASE, TAXOL-INDUCED KEYWDS 2 CHECKPOINT INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR N.KWIATKOWSKI,F.VILLA,A.MUSACCHIO,N.GRAY REVDAT 1 01-FEB-12 3ZTX 0 JRNL AUTH N.KWIATKOWSKI,X.DENG,J.WANG,L.TAN,F.VILLA,S.SANTAGUIDA, JRNL AUTH 2 H.C.HUANG,T.MITCHISON,A.MUSACCHIO,N.GRAY JRNL TITL SELECTIVE AURORA KINASE INHIBITORS IDENTIFIED USING A JRNL TITL 2 TAXOL- INDUCED CHECKPOINT SENSITIVITY SCREEN. JRNL REF ACS CHEM.BIOL. V. 7 185 2012 JRNL REFN ISSN 1554-8929 JRNL PMID 21992004 JRNL DOI 10.1021/CB200305U REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0072 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.68 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 99.61 REMARK 3 NUMBER OF REFLECTIONS : 47899 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.18775 REMARK 3 R VALUE (WORKING SET) : 0.18569 REMARK 3 FREE R VALUE : 0.22597 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.1 REMARK 3 FREE R VALUE TEST SET COUNT : 2561 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.950 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.001 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3544 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.22 REMARK 3 BIN R VALUE (WORKING SET) : 0.222 REMARK 3 BIN FREE R VALUE SET COUNT : 158 REMARK 3 BIN FREE R VALUE : 0.270 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5218 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 285 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.020 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.04 REMARK 3 B22 (A**2) : 0.18 REMARK 3 B33 (A**2) : -0.17 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : -0.07 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.172 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.153 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.102 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.507 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5433 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7342 ; 1.640 ; 1.989 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 629 ; 5.996 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 264 ;34.924 ;22.765 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 980 ;16.417 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 49 ;17.318 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 752 ; 0.110 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4166 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3149 ; 0.991 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5104 ; 1.792 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2284 ; 2.789 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2235 ; 4.636 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 3ZTX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-JUL-11. REMARK 100 THE PDBE ID CODE IS EBI-48994. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9334 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD (QUANTUM 210) REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 60077 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.85 REMARK 200 RESOLUTION RANGE LOW (A) : 35.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 2.8 REMARK 200 R MERGE (I) : 0.06 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.30 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.8 REMARK 200 R MERGE FOR SHELL (I) : 0.40 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.90 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.18200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -23.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 78 REMARK 465 ALA A 79 REMARK 465 LEU A 80 REMARK 465 ALA A 81 REMARK 465 GLU A 82 REMARK 465 MET A 83 REMARK 465 PRO A 84 REMARK 465 LYS A 85 REMARK 465 ARG A 86 REMARK 465 SER A 357 REMARK 465 THR A 358 REMARK 465 GLN A 359 REMARK 465 SER A 360 REMARK 465 LYS A 361 REMARK 465 GLY B 100 REMARK 465 LYS B 101 REMARK 465 GLY B 102 REMARK 465 LYS B 103 REMARK 465 PHE B 104 REMARK 465 GLN B 356 REMARK 465 SER B 357 REMARK 465 THR B 358 REMARK 465 GLN B 359 REMARK 465 SER B 360 REMARK 465 LYS B 361 REMARK 465 PRO C 797 REMARK 465 ASN C 838 REMARK 465 LYS C 839 REMARK 465 SER C 840 REMARK 465 PRO D 797 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 87 CB CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 158 -178.14 -172.07 REMARK 500 ASP A 162 -157.26 -129.34 REMARK 500 ASP A 216 42.44 -152.84 REMARK 500 SER A 243 -55.54 -129.20 REMARK 500 ARG A 245 172.14 -52.45 REMARK 500 ASN B 106 -61.30 108.30 REMARK 500 ASN B 158 -173.93 -173.91 REMARK 500 ARG B 163 -64.53 -20.79 REMARK 500 ASP B 216 43.77 -152.35 REMARK 500 LYS D 817 70.73 -117.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 PHE A 104 23.9 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZTX A1357 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZTX B1356 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2BFX RELATED DB: PDB REMARK 900 MECHANISM OF AURORA-B ACTIVATION BY INCENP AND REMARK 900 INHIBITION BY HESPERADIN. REMARK 900 RELATED ID: 2VGO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH REMARK 900 REVERSINE INHIBITOR REMARK 900 RELATED ID: 2VRX RELATED DB: PDB REMARK 900 STRUCTURE OF AURORA B KINASE IN COMPLEX WITH ZM447439 REMARK 900 RELATED ID: 2VGP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH REMARK 900 A AMINOTHIAZOLE INHIBITOR REMARK 900 RELATED ID: 2BFY RELATED DB: PDB REMARK 900 COMPLEX OF AURORA-B WITH INCENP AND HESPERIDIN. DBREF 3ZTX A 78 361 UNP Q6DE08 AUKBA_XENLA 78 361 DBREF 3ZTX B 78 361 UNP Q6DE08 AUKBA_XENLA 78 361 DBREF 3ZTX C 797 840 UNP O13024 INCEA_XENLA 797 840 DBREF 3ZTX D 797 840 UNP O13024 INCEA_XENLA 797 840 SEQRES 1 A 284 THR ALA LEU ALA GLU MET PRO LYS ARG LYS PHE THR ILE SEQRES 2 A 284 ASP ASP PHE ASP ILE GLY ARG PRO LEU GLY LYS GLY LYS SEQRES 3 A 284 PHE GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN ASN LYS SEQRES 4 A 284 PHE ILE MET ALA LEU LYS VAL LEU PHE LYS SER GLN LEU SEQRES 5 A 284 GLU LYS GLU GLY VAL GLU HIS GLN LEU ARG ARG GLU ILE SEQRES 6 A 284 GLU ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG SEQRES 7 A 284 MET TYR ASN TYR PHE HIS ASP ARG LYS ARG ILE TYR LEU SEQRES 8 A 284 MET LEU GLU PHE ALA PRO ARG GLY GLU LEU TYR LYS GLU SEQRES 9 A 284 LEU GLN LYS HIS GLY ARG PHE ASP GLU GLN ARG SER ALA SEQRES 10 A 284 THR PHE MET GLU GLU LEU ALA ASP ALA LEU HIS TYR CYS SEQRES 11 A 284 HIS GLU ARG LYS VAL ILE HIS ARG ASP ILE LYS PRO GLU SEQRES 12 A 284 ASN LEU LEU MET GLY TYR LYS GLY GLU LEU LYS ILE ALA SEQRES 13 A 284 ASP PHE GLY TRP SER VAL HIS ALA PRO SER LEU ARG ARG SEQRES 14 A 284 ARG TPO MET CYS GLY THR LEU ASP TYR LEU PRO PRO GLU SEQRES 15 A 284 MET ILE GLU GLY LYS THR HIS ASP GLU LYS VAL ASP LEU SEQRES 16 A 284 TRP CYS ALA GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY SEQRES 17 A 284 MET PRO PRO PHE ASP SER PRO SER HIS THR GLU THR HIS SEQRES 18 A 284 ARG ARG ILE VAL ASN VAL ASP LEU LYS PHE PRO PRO PHE SEQRES 19 A 284 LEU SER ASP GLY SER LYS ASP LEU ILE SER LYS LEU LEU SEQRES 20 A 284 ARG TYR HIS PRO PRO GLN ARG LEU PRO LEU LYS GLY VAL SEQRES 21 A 284 MET GLU HIS PRO TRP VAL LYS ALA ASN SER ARG ARG VAL SEQRES 22 A 284 LEU PRO PRO VAL TYR GLN SER THR GLN SER LYS SEQRES 1 B 284 THR ALA LEU ALA GLU MET PRO LYS ARG LYS PHE THR ILE SEQRES 2 B 284 ASP ASP PHE ASP ILE GLY ARG PRO LEU GLY LYS GLY LYS SEQRES 3 B 284 PHE GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN ASN LYS SEQRES 4 B 284 PHE ILE MET ALA LEU LYS VAL LEU PHE LYS SER GLN LEU SEQRES 5 B 284 GLU LYS GLU GLY VAL GLU HIS GLN LEU ARG ARG GLU ILE SEQRES 6 B 284 GLU ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG SEQRES 7 B 284 MET TYR ASN TYR PHE HIS ASP ARG LYS ARG ILE TYR LEU SEQRES 8 B 284 MET LEU GLU PHE ALA PRO ARG GLY GLU LEU TYR LYS GLU SEQRES 9 B 284 LEU GLN LYS HIS GLY ARG PHE ASP GLU GLN ARG SER ALA SEQRES 10 B 284 THR PHE MET GLU GLU LEU ALA ASP ALA LEU HIS TYR CYS SEQRES 11 B 284 HIS GLU ARG LYS VAL ILE HIS ARG ASP ILE LYS PRO GLU SEQRES 12 B 284 ASN LEU LEU MET GLY TYR LYS GLY GLU LEU LYS ILE ALA SEQRES 13 B 284 ASP PHE GLY TRP SER VAL HIS ALA PRO SER LEU ARG ARG SEQRES 14 B 284 ARG TPO MET CYS GLY THR LEU ASP TYR LEU PRO PRO GLU SEQRES 15 B 284 MET ILE GLU GLY LYS THR HIS ASP GLU LYS VAL ASP LEU SEQRES 16 B 284 TRP CYS ALA GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY SEQRES 17 B 284 MET PRO PRO PHE ASP SER PRO SER HIS THR GLU THR HIS SEQRES 18 B 284 ARG ARG ILE VAL ASN VAL ASP LEU LYS PHE PRO PRO PHE SEQRES 19 B 284 LEU SER ASP GLY SER LYS ASP LEU ILE SER LYS LEU LEU SEQRES 20 B 284 ARG TYR HIS PRO PRO GLN ARG LEU PRO LEU LYS GLY VAL SEQRES 21 B 284 MET GLU HIS PRO TRP VAL LYS ALA ASN SER ARG ARG VAL SEQRES 22 B 284 LEU PRO PRO VAL TYR GLN SER THR GLN SER LYS SEQRES 1 C 44 PRO ILE PRO ALA TRP ALA SER GLY ASN LEU LEU THR GLN SEQRES 2 C 44 ALA ILE ARG GLN GLN TYR TYR LYS PRO ILE ASP VAL ASP SEQRES 3 C 44 ARG MET TYR GLY THR ILE ASP SER PRO LYS LEU GLU GLU SEQRES 4 C 44 LEU PHE ASN LYS SER SEQRES 1 D 44 PRO ILE PRO ALA TRP ALA SER GLY ASN LEU LEU THR GLN SEQRES 2 D 44 ALA ILE ARG GLN GLN TYR TYR LYS PRO ILE ASP VAL ASP SEQRES 3 D 44 ARG MET TYR GLY THR ILE ASP SER PRO LYS LEU GLU GLU SEQRES 4 D 44 LEU PHE ASN LYS SER MODRES 3ZTX TPO A 248 THR PHOSPHOTHREONINE MODRES 3ZTX TPO B 248 THR PHOSPHOTHREONINE HET TPO A 248 11 HET TPO B 248 11 HET ZTX A1357 32 HET ZTX B1356 32 HETNAM TPO PHOSPHOTHREONINE HETNAM ZTX 2-((4-(4-HYDROXYPIPERIDIN-1-YL)PHENYL)AMINO)- HETNAM 2 ZTX 5,11-DIMETHYL-5H-BENZO[E]PYRIMIDO [5,4-B][1, HETNAM 3 ZTX 4]DIAZEPIN-6(11H)-ONE HETSYN TPO PHOSPHONOTHREONINE FORMUL 3 TPO 2(C4 H10 N O6 P) FORMUL 4 ZTX 2(C24 H26 N6 O2) FORMUL 5 HOH *285(H2 O) HELIX 1 1 THR A 89 ASP A 91 5 3 HELIX 2 2 LYS A 126 GLU A 132 1 7 HELIX 3 3 VAL A 134 SER A 146 1 13 HELIX 4 4 LEU A 178 GLY A 186 1 9 HELIX 5 5 ASP A 189 ARG A 210 1 22 HELIX 6 6 LYS A 218 GLU A 220 5 3 HELIX 7 7 THR A 252 LEU A 256 5 5 HELIX 8 8 PRO A 257 GLU A 262 1 6 HELIX 9 9 LYS A 269 GLY A 285 1 17 HELIX 10 10 SER A 293 ASN A 303 1 11 HELIX 11 11 SER A 313 LEU A 324 1 12 HELIX 12 12 HIS A 327 ARG A 331 5 5 HELIX 13 13 PRO A 333 GLU A 339 1 7 HELIX 14 14 HIS A 340 SER A 347 1 8 HELIX 15 15 THR B 89 ASP B 91 5 3 HELIX 16 16 LYS B 126 LYS B 131 1 6 HELIX 17 17 VAL B 134 SER B 146 1 13 HELIX 18 18 LEU B 178 GLY B 186 1 9 HELIX 19 19 ASP B 189 ARG B 210 1 22 HELIX 20 20 LYS B 218 GLU B 220 5 3 HELIX 21 21 THR B 252 LEU B 256 5 5 HELIX 22 22 PRO B 257 GLU B 262 1 6 HELIX 23 23 LYS B 269 GLY B 285 1 17 HELIX 24 24 SER B 293 ASN B 303 1 11 HELIX 25 25 SER B 313 LEU B 324 1 12 HELIX 26 26 HIS B 327 ARG B 331 5 5 HELIX 27 27 PRO B 333 GLU B 339 1 7 HELIX 28 28 HIS B 340 SER B 347 1 8 HELIX 29 29 PRO C 799 ALA C 802 5 4 HELIX 30 30 SER C 803 LYS C 817 1 15 HELIX 31 31 ASP C 820 TYR C 825 1 6 HELIX 32 32 LYS C 832 PHE C 837 1 6 HELIX 33 33 PRO D 799 ALA D 802 5 4 HELIX 34 34 SER D 803 LYS D 817 1 15 HELIX 35 35 ASP D 820 TYR D 825 1 6 HELIX 36 36 LYS D 832 LEU D 836 5 5 SHEET 1 AA 5 PHE A 93 LYS A 101 0 SHEET 2 AA 5 GLY A 105 GLU A 112 -1 O VAL A 107 N LEU A 99 SHEET 3 AA 5 PHE A 117 PHE A 125 -1 O PHE A 117 N GLU A 112 SHEET 4 AA 5 ARG A 165 LEU A 170 -1 O ILE A 166 N LEU A 124 SHEET 5 AA 5 MET A 156 HIS A 161 -1 N TYR A 157 O MET A 169 SHEET 1 AB 3 GLY A 176 GLU A 177 0 SHEET 2 AB 3 LEU A 222 MET A 224 -1 N MET A 224 O GLY A 176 SHEET 3 AB 3 LEU A 230 ILE A 232 -1 O LYS A 231 N LEU A 223 SHEET 1 AC 2 VAL A 212 ILE A 213 0 SHEET 2 AC 2 VAL A 239 HIS A 240 -1 O VAL A 239 N ILE A 213 SHEET 1 BA 5 PHE B 93 PRO B 98 0 SHEET 2 BA 5 VAL B 107 GLU B 112 -1 O LEU B 109 N GLY B 96 SHEET 3 BA 5 PHE B 117 PHE B 125 -1 O PHE B 117 N GLU B 112 SHEET 4 BA 5 ARG B 165 LEU B 170 -1 O ILE B 166 N LEU B 124 SHEET 5 BA 5 MET B 156 HIS B 161 -1 N TYR B 157 O MET B 169 SHEET 1 BB 3 GLY B 176 GLU B 177 0 SHEET 2 BB 3 LEU B 222 MET B 224 -1 N MET B 224 O GLY B 176 SHEET 3 BB 3 LEU B 230 ILE B 232 -1 O LYS B 231 N LEU B 223 SHEET 1 BC 2 VAL B 212 ILE B 213 0 SHEET 2 BC 2 VAL B 239 HIS B 240 -1 O VAL B 239 N ILE B 213 LINK C ARG A 247 N TPO A 248 1555 1555 1.33 LINK C TPO A 248 N MET A 249 1555 1555 1.33 LINK C ARG B 247 N TPO B 248 1555 1555 1.33 LINK C TPO B 248 N MET B 249 1555 1555 1.32 CISPEP 1 PHE A 104 GLY A 105 0 -9.63 CISPEP 2 GLY B 105 ASN B 106 0 10.74 SITE 1 AC1 9 VAL A 107 ALA A 120 LEU A 170 GLU A 171 SITE 2 AC1 9 PHE A 172 ALA A 173 GLY A 176 GLU A 177 SITE 3 AC1 9 LEU A 223 SITE 1 AC2 8 ALA B 120 LEU B 170 GLU B 171 PHE B 172 SITE 2 AC2 8 ALA B 173 PRO B 174 GLY B 176 LEU B 223 CRYST1 45.634 66.364 116.679 90.00 96.56 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021913 0.000000 0.002520 0.00000 SCALE2 0.000000 0.015068 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008627 0.00000